A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder

NCT00189800 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Solifenacin succinate

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]